Eileen tracks developments in OTC drug research, manufacturing, regulation, finance, M&A and marketing. She favors stories on e-commerce trends and the industry's drive toward Rx-to-OTC drug switches. Eileen also contributes coverage on the dietary supplement industry. She has a keen eye for pieces that delve into the rising self-care movement and how it is raising the innovation bar for marketers.
Latest from Eileen Francis
The US FDA’s 20 May expert panel on talc discussed science behind the potential carcinogenicity of the cosmetic, food and drug ingredient, the importance of ‘good science’ in evaluating the substance and the need to find alternatives in each industry.
The FTC’s Green Guides proposed update was expected by the end of the Biden Administration and there’s no indication it will be unveiled soon, says Mary Engle, BBB National Programs Exec VP, Policy. She also discussed the importance of industry self-regulation of artificial intelligence.
The National Advertising Division expects cases involving ‘Made in the USA’ claims to increase given US tariffs, says NAD VP Phyllis Marcus. The topic was also addressed by BBB National Programs’ Mary Engle during IBA’s Cosmetics Convergence Virtual Spring Conference 14-15 May.
US Customs and Border Protection’s program allowing companies to recoup fees for imported goods that were destroyed or exported is applicable in the case of most of President Trump’s reciprocal tariffs. However, most cosmetic companies don’t make use of it.
MAC Cosmetics Appoints ‘Iconic’ Creative Director Nicola Formichetti as global creative director, while Revlon Consumer Products LLC partners with four-time GRAMMY-nominated artist, Ice Spice, in a “major step” in the revitalization of Revlon’s fragrance business.
Shiseido’s Drunk Elephant premium skin care range – acquired in 2019 – and its NARS brand dragged sales in the Americas region down almost 20% in the first quarter, the firm reported in a 12 May earnings presentation.